Want to join the conversation?
$CELG's sales from multiple myeloma drug Revlimid for 2015 increased by 16.5% from last year. This was primarily due to increased unit sales in both U.S. and international markets in addition to price rises in the U.S. market. Increases in market penetration and treatment duration of patients contributed to the increase in U.S. unit sales.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!